Agios Pharmaceuticals (AGIO) Earnings Date & Reports

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AGIO is expected to report earnings to fall 4.73% to -161 cents per share on July 30

Agios Pharmaceuticals AGIO Stock Earnings Reports

Q2'26

Est.

$-1.61

Q1'26

Beat

by $0.12

Q4'25

Beat

by $0.09

Q3'25

Beat

by $0.12

Q2'25

Missed

by $0.12

The last earnings report on April 29 showed earnings per share of -169 cents, beating the estimate of -180 cents. With 2.24M shares outstanding, the current market capitalization sits at 2.03B.

View a ticker or compare two or three

Compare

AGIO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AGIO